Conor Benn’s failed drugs test to be investigated by anti-doping body, BBBofC confirms
The IndependentSign up to our free sport newsletter for all the latest news on everything from cycling to boxing Sign up to our free sport email for all the latest news Sign up to our free sport email for all the latest news SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy UK Anti-Doping has launched an investigation into Conor Benn’s failed drugs test that saw his grudge match against Chris Eubank Jr postponed last week. The 157lbs catchweight fight at the O2 Arena was called off after it was revealed that last month Benn tested positive for trace amounts of fertility drug clomiphene, which elevates testosterone levels in men. A statement said: “Following the British Boxing Board of Control Limited’s decision on 4th October 2022 to prohibit the contest between Chris Eubank Jr and Conor Benn that was scheduled to take place on 8th October 2022, the board is aware that it has been widely reported in the press that an ‘A’ sample provided by Mr Benn to the Voluntary Anti-Doping Association tested positive for a prohibited substance. Benn, who has not yet been suspended, returned the positive result in a test conducted by the Voluntary Anti-Doping Association, prompting the BBBofC to declare the fight “prohibited” and “not in the interests of boxing”.